In this section we give you an overview of the latest news and updates regarding the development of DEBx Medical and our product DEBRICHEM. Follow us on LinkedIn for more up-to-date content!
Peer-reviewed paper on cost-effectiveness of Debrichem published in Journal of Wound Care and presented by Prof. Julian F. Guest at EWMA conference. Topical debridement gel
We are delighted to be attending the joint EWMA & Journées Cicatrisations Conference on 23-25 May 2022 in Paris next week! During the conference, we
This week we will be presenting our novel debridement agent that addresses the biofilm in chronic wounds during the World Union of Wound Healing Societies
Despite the best intentions for bringing together the international wound community in Paris, it has become clear that the most prudent decision with respect to
Healthcare systems have been severely impacted by the COVID-19 pandemic, both in terms of workload and the resources, what has impacted patients who require treatment for
Rotterdam, The Netherlands, September 28, 2021 – DEBx Medical, the Dutch medical technology company revolutionizing the management of chronic wounds, announced today that the Company
DEBx Medical is excited to present a special Biofilm session at the Polish 2nd Online Wound Treatment conference with Prof Gregory Schulz and B.J. Quint
DEBx Medical is attending the meeting of Soceidade Portuguesa de Cirurgia Plástica Reconstrutiva e Estetica, at Pestana Palace in Lisbon. Bert Quint, CEO will present on the
